Visp, Switzerland

Christoph Kiziak

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christoph Kiziak: Innovator in Protein Production

Introduction

Christoph Kiziak is a notable inventor based in Visp, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the production of proteins through engineered host cells. With a total of 5 patents to his name, Kiziak's work has advanced the understanding and application of recombinant technology.

Latest Patents

Kiziak's latest patents include innovative methods for producing proteins of interest. One of his notable inventions is a eukaryotic host cell engineered to produce a heterologous protein of interest (POI). This cell is genetically modified to reduce the production of at least one of three different endogenous host cell proteins (HCP), enhancing the efficiency of POI production. Another significant patent focuses on the regulation of inducible promoters in recombinant bacterial host cells. This invention allows for the production of heterologous polypeptides by ensuring that the bacterial host cell cannot deactivate the promoter controlling the expression of the polypeptide in the absence of an inducer.

Career Highlights

Throughout his career, Christoph Kiziak has worked with prominent companies in the biotechnology sector, including Lonza AG. His expertise in protein production and genetic engineering has positioned him as a key figure in his field.

Collaborations

Kiziak has collaborated with esteemed colleagues such as Josef Altenbuchner and Marian Wenzel. These partnerships have further enriched his research and development efforts.

Conclusion

Christoph Kiziak's innovative work in protein production and genetic engineering has made a lasting impact on biotechnology. His patents reflect a commitment to advancing the field and improving methods for producing valuable proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…